• The Chronic Disease Models area has been significantly expanded. Twelve major disease states, including diabetes, asthma, low back pain, and coronary artery disease, are now included with quality management metrics and predictive modeling analytics.
• High-risk and/or high-cost conditions such as pregnancy, obesity and substance abuse have been added to the system in the modeling area. These Medical Condition Models include projections of forward financial risk for benefit purchasers.
• Health Risk Assessment (HRA) data is now routinely captured into the data warehouse across many different vendors and survey formats. HRAs are used to assess forward cost and absenteeism risk as a supplement to claims and enrollment data.
• Worker’s Comp and Disability Income benefits are now fully covered with a separate module.
• The Benefit Design Modeler has been expanded to consolidate the historical experience of multiple and diverse plans for a single employer into the baseline for a forward actuarial projection.
  

Nelson Rosenbaum, Ph.D., President of PSIMedica notes, “We designed the expanded features of CKM Version 7.0 to meet the emerging analytic needs of large employers and other benefits purchasers. Employers now need to be highly proactive about the health and productivity of their employees. PSIMedica is providing the essential tools to support that stance”

About PSIMedica
PSIMedica, headquartered in Bethesda, MD, is the health informatics division of Bio-Reference Laboratories, Inc., the largest regional clinical laboratory in the Northeast U.S. Bio-Reference Labs is a publicly traded corporation (BRLI-NASDAQ). PSIMedica’s current applications, among others, include health plan benefit design modeling, support for health and productivity initiatives such as disease management and provider pay for performance, and employee healthcare report cards.